Biovie Inc
(BIVI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,876 | 13,196 | 37 | 4 | 3 |
| Other current assets | 27 | 52 | 376 | 577 | 551 |
| TOTAL | $11,904 | $13,248 | $413 | $581 | $554 |
| Non-Current Assets | |||||
| Intangibles | 1,556 | 1,614 | 1,671 | 1,728 | 1,786 |
| TOTAL | $1,556 | $1,614 | $1,671 | $1,728 | $1,786 |
| Total Assets | $13,460 | $14,861 | $2,084 | $2,309 | $2,340 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 849 | 28 | 30 |
| Accounts payable and accrued liabilities | 322 | 203 | 1,259 | 1,300 | 1,085 |
| Other current liabilities | N/A | N/A | 21,412 | 2,881 | 3,247 |
| TOTAL | $322 | $203 | $23,520 | $4,654 | $4,384 |
| Non-Current Liabilities | |||||
| Long Term Debt | 63 | 63 | 63 | N/A | N/A |
| TOTAL | $63 | $63 | $63 | $N/A | $N/A |
| Total Liabilities | $385 | $266 | $23,583 | $4,654 | $4,384 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 139 | 139 | 52 | 52 | 52 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -90,360 | -87,302 | -41,038 | -21,884 | -21,517 |
| TOTAL | $13,075 | $14,596 | $-21,499 | $-2,345 | $-2,044 |
| Total Liabilities And Equity | $13,460 | $14,861 | $2,084 | $2,309 | $2,340 |